by John Conrad | Mar 21, 2024 | Policy News
Calling all Illinois BioPharma startups! Join iBIO for the annual BIO Fly-In in Washington D.C. on April 16th & 17th. This is a fantastic opportunity to connect with policymakers and champion the life sciences industry! What is the BIO Fly-In? This event brings...
by John Conrad | Jan 2, 2024 | Policy News
We want to take a moment to recognize Congressman Brad Schneider for his leadership and advocacy on behalf of the biopharmaceutical industry. His recent letter to the U.S. Trade Representative opposing the proposed expansion of the waiver of IP rights for COVID...
by John Conrad | Nov 20, 2023 | Policy News
iBIO, a life sciences industry association representing over 91,000 jobs in Illinois, joined over 100 stakeholders last week in urging Congress to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA). PAHPA expired on September 30, 2023, requiring...
by John Conrad | Nov 9, 2023 | Policy News
As startup funding is increasingly harder for Illinois startup companies to raise, it is more critical than ever that we support American innovation and job creation. However, a harmful change in the tax code threatens to stifle these efforts, especially for small...
by John Conrad | Oct 24, 2023 | iBIO News, Policy News
Key Points • iBIO is advocating for HR1651, the Ensuring Patient Access to Critical Breakthrough Products Act, to provide seniors with quicker access to life-saving medical technologies. • This bipartisan legislation seeks to create a 4-year automatic coverage period...
by John Conrad | Oct 2, 2023 | iBIO News, Policy News
Representatives John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC) have recently introduced the Optimizing Research Progress Hope And New Cures (ORPHAN Cures Act). This legislation is a significant step in addressing the negative impact of the Inflation Reduction Act...
